For the Inventor, By the Inventor

Enter assignee name

Suwon, South Korea

Medicinal Bioconvergence Research Center

Calculating rank

USPTO Granted Patents = 18

% Expired Patents = 22.2

EPO Patents = 6

Forward Citations = 8

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Sunghoon Kim (16 out of 134 patents)

Dae Gyu Kim (4 out of 8 patents)

Jin Woo Choi (4 out of 117 patents)

4. Min Chul Park (4 out of 17 patents)

5. Chul Ho Lee (2 out of 57 patents)

6. Inwon Park (2 out of 2 patents)

7. Pil Han Kim (2 out of 2 patents)

8. Jung Min Han (2 out of 5 patents)

9. Nam Hoon Kwon (1 out of 7 patents)

10. Peter Charles Goughnour (1 out of 1 patent)

11. Yeseul Kim (1 out of 2 patents)

12. Joon-Sung Park (1 out of 5 patents)

13. Kyunggon Kim (1 out of 1 patent)

14. Jee Sun Yang (1 out of 1 patent)

15. Yon-Sik Choi (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 11649231 - Compound as mTOR inhibitor and use thereof (2023-05-16),

2. 11442057 - Method for screening anticancer agent inhibiting binding of AIMP2-DX2 and HSP70 (2022-09-13),

3. 11360093 - Colorectal cancer diagnostic composition, and method for detecting diagnostic marker (2022-06-14),

4. 11173192 - Anti-RNA virus composition comprising EPRS protein or fragment thereof (2021-11-16),

5. 11029504 - Window apparatus for obtaining microscopic image of in vivo breast tissue and method for obtaining image using same (2021-06-08),

6. 10677806 - Composition for diagnosing follicular thyroid carcinoma using expression level of aminoacyl-tRNA synthetase-related protein and method for detecting diagnostic marker (2020-06-09),

7. 10646547 - Polypeptide having chemokine activity and uses thereof (2020-05-12),

8. 10437035 - Microaspiration-based lung window apparatus for obtaining microscopic image of in vivo lung tissue and method for obtaining image using same (2019-10-08),

9. 10258674 - Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same (2019-04-16),

10. 10139394 - Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase (2018-11-27),

11. 10130611 - Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis (2018-11-20),

12. 9945859 - Anti-KRS monoclonal antibody and use thereof (2018-04-17),

13. 9944713 - Antibody specific to the AIMP2-DX2 (2018-04-17),

14. 9539236 - Pharmaceutical composition for preventing or treating cancer (2017-01-10),

15. 9511085 - Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase (2016-12-06),

Company Overview

The Medicinal Bioconvergence Research Center, located in Suwon, South Korea, focuses on advancing the integration of biological and medicinal sciences. The center specializes in developing innovative therapeutic solutions and biotechnological applications that address complex health challenges. Its research spans various domains, including drug discovery, regenerative medicine, and personalized healthcare, aiming to foster collaboration between academia and industry to enhance the efficacy of medical treatments and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#21 in Suwon

#690 in South Korea

#34,263 in the World

Suwon, South Korea

Medicinal Bioconvergence Research Center

Forward Citations = 8

33 inventors:

Sunghoon Kim (16 out of 134 patents)

Dae Gyu Kim (4 out of 8 patents)

Jin Woo Choi (4 out of 117 patents)

4. Min Chul Park (4 out of 17 patents)

5. Chul Ho Lee (2 out of 57 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medicinal Bioconvergence Research Center. Retrieved from https://idiyas.com/company/medicinal-bioconvergence-research-center

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…